RE: Question24 Jun 2021 17:14
Xviolet,
I have moved from an very positive investor regarding LFT/Antigen tests and manufacturing to now unsure for many reasons, they currently have a poor reputation among medical/health community, here in Ireland when Lidl started selling them they were referred to as similar to "snake oil" also if you google Covid antigen tests for sale...you will be surprised how huge the choice is, as far as AVCT is concerned I do think they missed the boat, 14 months to get a test to market in what now appears to be quite a full market, those on the AVCT board will say " but our test is the best" maybe it is better than most, but the average Joe is not going to ask the person in the chemist what the S & S figures are, AVCT only chance of success is substantial orders sooner rather than later, if however you think that LFT/LFD testing for all is the way forward to open up work/social/travel etc (Which I do) then investment in the sector is warrented but expierance tells me that will only happen if governments tell their populations to test themselves regularly. I had a large holding in AVCT but have reduced by 66% but am very close to selling the remainder however have done well from that investment, but not so well with my ABDX/ODX holdings, on another point take a look at DVRG low MKT CAP /SP could be a great growth story if you have some patience, i was an investor in MWG/Modern water which i did well in, and DVRG took them over last year, read todays RNS, Cheers Roly